Tung Truong-Thanh

20PUBLICATIONS
19CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsClinical pharmacology and therapeuticsMolecular medicineSignal transduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 14, 2026
2-Oxoindoline-based hydroxamic acids: novel HDAC inhibitors with promising anticancer activity.

|Nov 11, 2025
Exploration of 2-Mercaptoquinazolin-4(3H)-one Based N-Hydroxyheptanamides as Histone Deacetylase Inhibitors: Design, Synthesis, and Anticancer Bioevaluation.

Le Thi Thao, Hwa Kyung Kim, Hoang Kim Ngoc

|Sep 05, 2025
Indolicidin derivatives as potent dual-action antifungal and antibacterial agents for the treatment of skin infections: A comprehensive study from in vitro to in vivo evaluation.

Hoa Ngo Van, Huy Luong Xuan, Hai Le Viet

|Aug 13, 2025
Harnessing Chemical Diversity to Disarm Bacterial Communication for 25 Years: Natural Products, Repurposed Drugs, Peptides, and Synthetic Quorum Sensing Inhibitors.

Tung Truong-Thanh, Anh Nguyen Phuong, Linh Nguyen Khanh

|Jul 23, 2025
Novel quinazoline-triazole-based N-hydroxybenzamides/N-hydroxypropenamides as HDAC inhibitors: design, synthesis, biological evaluation, and docking studies.

Nguyen Phuong Dung, Hwa Kyung Kim, Nguyen Thi Nga

|Aug 09, 2024
Mechanism of allosteric inhibition of human p97/VCP ATPase and its disease mutant by triazole inhibitors.

Purbasha Nandi, Kira DeVore, Feng Wang

Pageof 4

Frequent Collaborators

5 joint publications

Nguyen-Hai Nam

4 joint publications

Huy Xuan Luong

3 joint publications

John Nielsen

3 joint publications

Søren Brøgger Christensen